The Year Ahead: Pharmaceuticals & Healthcare In 2018

 

This special report looks forward to 2018 and identifies the pharmaceuticals & healthcare markets that will present the most opportunity and risks over the year.

Key content includes:

  • Critical analysis of the main issues facing the pharmaceutical & healthcare industry
  • Mapping the increasing complexity of healthcare sector stakeholders
  • Quantification and qualification of global health risks
  • The latest expenditure forecasts and evidence-based views
The Year Ahead: Pharmaceuticals & Healthcare In 2018
Product Price
$795.00

The pharmaceutical sector is expected to have a challenging 2018. In the US, tax reform will reduce new treatments for rare diseases. Concerns over the continuity of the operations of the European Medicines Agency will escalate. With growing and ageing populations across the Central and Eastern Europe region, healthcare funding is coming under increasing strain. Reduced economic activity in the Latin America region is likely to have knock-on effects on pharmaceutical market growth, while greater political uncertainty may stall much-needed legislative development. Despite these issues, we also see bright spots in the sector in 2018. Increasing efforts from the governments in the region to develop the Asia Pacific pharmaceutical sector will bode well for the market's attractiveness to investors. Additionally, we expect 2018 to deliver notable regulatory progress in the pharmaceutical and healthcare-related space in Africa - including the launch of the African Medicines Agency.

This special report takes an in-depth look at global and regional industry trends, providing a robust outlook for the industry in 2018.